At McMillan Medical Group, we partner with medical and device companies to distribute innovative medical solutions designed to enhance patient care and streamline practice efficiency. We recognize that medical products used in your practice should be the highest of quality, and scientifically backed to provide the best of outcomes. When it comes to coverage, McMillan Medical Group partners with companies that offer a variety of options to suit your patients' needs; from private insurance, Medicare, Medicaid and Self-Pay, we will provide the support needed to successfully guide your patients to the procedures that make both medical and financial sense.
At McMillan Medical Group, our mission is to provide comprehensive medical solutions tailored to your practice; but those products need to make financial business sense. That is why McMillan Medical Group only partners with the most innovative and dynamic medical devices and solutions that benefit the practice as well. We also ensure the support you need when it comes to training, marketing and ordering. Trust in solutions that prioritize quality and effectiveness for better outcomes while not ignoring the bottom line.
The PanPlasty Instrument System is uniquely designed to precisely target and delivery biomaterials to ensure precise treatment of intraosseous lesions potentially lessening/alleviating patient pain and delaying the need for more complex and invasive arthroplasty surgical procedures.
Knee pain caused by osteoarthritis is suffered by millions of people worldwide10. TriVisc*, a 3-injection Hyaluronic Acid , and GenVisc 850*, a 5-injection Hyaluronic Acid, may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics.
Tropocells® PRP system utilizes a patented separator gel technology to isolate the platelets while eliminating the undesirable components such as red blood cells and inflammatory white blood cells. This can both promote cell growth and tissue regeneration for optimal healing.
HIGH PLATELET CONCENTRATION
Optimal platelet recovery:
80% (+/- 10%) Platelet Yield.
PURE PRP
The system removes 99.9% of red blood cells and 92-96% of neutrophils, while preserving the monocytes and lymphocytes.
MONOCYTE-RICH
Maximizes monocytes for platelet activation. 86.2% of white blood cells in PRP preparation are monocytes.